To Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia
Status:
Active, not recruiting
Trial end date:
2020-10-12
Target enrollment:
Participant gender:
Summary
To Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe
Versus Monotherapy of Pitavastatin in Patients With Primary Hypercholesterolemia.